GNS-1480 (YH25448) - Oral 3rd-generation EGFR inhibitor for non-small cell lung cancer (NSCLC) - Targeting various single and double mutants of EGFR including T790M/L858R and T790M/Del19 4th–generation EGFR inhibitor program - Targeting
http://www.genosco.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
2 seconds
16x16
32x32
1&1 Internet, Inc. - http://1and1.com/contact
Oneandone Private Registration
701 Lee ●●●●●●●●uite 300
Ches●●●●rook , PA, 19087
US
View this contact
1&1 Internet, Inc. - http://1and1.com/contact
Oneandone Private Registration
701 Lee ●●●●●●●●uite 300
Ches●●●●rook , PA, 19087
US
View this contact
1&1 Internet, Inc. - http://1and1.com/contact
Oneandone Private Registration
701 Lee ●●●●●●●●uite 300
Ches●●●●rook , PA, 19087
US
View this contact
BUY YOUR DOMAIN
15
YEARS
4
MONTHS
7
DAYS
1 & 1 INTERNET AG
WHOIS : whois.schlund.info
REFERRED : http://1and1.com
PAGES IN
THIS WEBSITE
4
SSL
EXTERNAL LINKS
11
SITE IP
198.46.81.222
LOAD TIME
1.965 sec
SCORE
6.2
Genosco | genosco.com Reviews
https://genosco.com
GNS-1480 (YH25448) - Oral 3rd-generation EGFR inhibitor for non-small cell lung cancer (NSCLC) - Targeting various single and double mutants of EGFR including T790M/L858R and T790M/Del19 4th–generation EGFR inhibitor program - Targeting
genosco.com
Genosco.com - About Us
http://genosco.com/about_us.html
Genosco is a leader in the discovery and development of novel small molecule drugs to treat human diseases having the greatest un-met medical need utilizing a highly targeted approach. The company has utilized its proprietary Master Scaffolds to develop novel pharmaceuticals in a number of therapeutic areas, including inflammation, cancer and Parkinson s diseases. Currently we are working actively on SYK, EGFRm , FGFR4, LRRK2 and FLT3 kinase targets with highly selective and potent inhibitors.
Genosco.com - Intellectual Property
http://genosco.com/intellectual_property.html
Genosco has filed patent applications in major territories to protect all compound series in SYK, FLT3, EGFR, FGFR4 and LRRK2 programes.
Genosco.com - Pipeline
http://genosco.com/pipeline.html
Our pipeline include SYK, EGFR mutants, EGFR4, FLT3, and LRRK2 signal network related disease pathway. Details of each project. SYK-Inhibitor Genosco A Complex. MMPSense and ProSense is the trademark of PerkinElmer. Our selective FGFR4 inhibitor program has generated potent and selective lead hits sparing subfamily FGFR1, 2, and 3 and other kinases and is at lead optimization stage.
Genosco.com - Leadership
http://genosco.com/leadership.html
Jong Sung (John) Koh, Ph.D.
TOTAL PAGES IN THIS WEBSITE
4
Welcome to osteopeak
http://www.osteopeak.com/differentcare.htm
Different People need Different Care. Since everyone has a different bone remodeling process depending on age, gender, and hormonal status, each person needs personalized bone care suitable to her/his own bone-remodeling process for obtaining the optimal peak bone mass and maintaining high bone mineral density. The personalized bone care is essential to achieve high bone formation at early age, peak bone mass before menopause, and slower rapid bone loss after menopause.*.
West Cambridge Science Park - About Us
http://www.wcsp.biz/about-us.html
West CAMBRIDGE SCIENCE PARK. Mon-Fri 8 am-5 pm EST,. ALL ABOUT WEST CAMBRIDGE SCIENCE PARK. West Cambridge Science Park, LLC. All Right Reserved.
Welcome to osteopeak
http://www.osteopeak.com/faq.htm
Q Who is Genosco? A Genosco is a bone-specialized bioengineering company, which develops and commercializes products associated with bone disease such as osteoporosis and arthritis. It also commercializes biomaterials including bone substitutes and develops drug delivery system of antibiotics and anticancer agents. Q Why does different individual need different care? During each stage of life, the balance. Maintain high bone mineral density. Q What is Osteoporosis? Q What is bone-remodeling process?
Welcome to osteopeak
http://www.osteopeak.com/cominfo.htm
Who Does Make OsteoPeak? Put Your Trust in Genosco. Genosco is a bone-specialized bioengineering company, which develops and commercializes products associated with bone disease such as osteoporosis and arthritis. It also commercializes biomaterials including bone substitutes and develops drug delivery system of antibiotics and anticancer agents. Advanced Formulations: The OsteoPeak Difference. OsteoPeak is not a typical line of natural medicines and supplements. You can feel confident carrying and r...
Welcome to Osteopeak.com
http://www.osteopeak.com/wheretobuy.htm
Amazon.com now provides the best possible experience for online personal-care shopping under their new Health and Personal Care Store. Http:/ www.cvs.com.
Welcome to osteopeak
http://www.osteopeak.com/differentyou.htm
Everyone wants healthy bone. But not everyone knows that bone is a living tissue that is continually being damaged by osteoclast cells and rebuilt by osteoblast cells throughout the lifespan. Without lifelong bone care, the activity of bone destruction rapidly surpasses bone formation, and bone will resulting in low bone mass that leads to an increase in the risk of fractures, particularly of the hip, spine, and wrists. Different People have Different Bone Remodeling Processes.
Welcome to osteopeak
http://www.osteopeak.com/newsflash.htm
Subtitle of the journal: A Clinician's Journal. Issue: April/May 2003 Vol.2 No.2. Poor bone health is everybody's concern:. Osteopeak offers personalized bone care solution. OCT USA introduces Osteopeak Natural. Now available at GNC, Osteopeak Natural stimulates new bone formation and inhibits bone destuction: organic, hormone-free bone care. Women: Reduce the possibility of weakened bones with a lifetime of bone health. Osteopeak offers first custom bone care solutions for women of all ages.
TOTAL LINKS TO THIS WEBSITE
11
Genoscience Pharma – We are changing the cancer landscape
Publications & Abstracts. Genoscience Pharma Is Innovating to Change the Cancer Landscape. To design, develop and commercialize novel therapies intended to improve patients' quality of life and resolve serious unmet medical healthcare needs. Liver cancer causes death more often than many other tumors, and patients are usually diagnosed with late-stage disease. Clinical significance of high expression of a specific solute carrier transporter in HCC. GNS561 a new quinoline derivative inhibits the growth of...
Under Construction genosciences.com
This website is under development. Check back soon for further updates. Are you interested in this domain? Let us help with Webnames.ca's Domain Brokering Service. Are you looking for a similar domain? Search for available domains like this one. Are you the owner of this domain? Start building your online presence using Webnames.ca's industry leading hosting plans. We make things easy. Contact us. We're just a phone call or email. Away, seven days a week.
Welcome - GenoScientific Molecular Diagnostics Laboratory
Your Partner in Cardiac Care. Performance you need. Now. Your Local DNA Expert. Behind Every Diagnosis There is Life. We Focus on Technology, so You Can Focus on Your Practice. Any questions or concerns? Search through our Alphabetical Laboratory Test Directory. Key strength of GenoScientific. Our laboratory is CLIA certified (Clinical Laboratory Improvement Amendment). Our facilities allow us to provide the very highest in quality testing in the fastest possible turnaround time. The laboratory is equipp...
GENOSCIISSORS (geno) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Deviant for 3 Years. Last Visit: 41 weeks ago. This deviant's activity is hidden. Deviant since Jul 14, 2013. This is the place where you can personalize your profile! Why," you ask? May 3, 2015.
Geno's Clothiers Leawood Kansas
Genosco
4th Gen EGFR Inhibitor. 2nd Gen SYK Inhibitor. We are always open to new potential opportunities to establish strategic collaborations. Genosco’s pipelines consist of two assets in Phase I and multiple preclinical programs. Genosco is an early clinical-stage biotechnology company pursuing the discovery and development of novel small-molecule drugs to treat patients with unmet medical needs. Selective SYK inhibitor for autoimmune disorders. Intravenous selective FLT3 inhibitor for acute myeloid leukemia.
Genosconstruction.com
This domain may be for sale. Backorder this Domain. This Domain Name Has Expired - Renewal Instructions.
GENOS Consulting inc.
GENOS Consulting inc. is a team of management consultants that help companies develop and implement customer centric business strategies, operational processes and culture re-alignments. Business Strategy Review and Alignment. IT/SAP End User Training knowledge. Experience, knowledge, a focus on customer issues and the belief that the bottom line is king underpin the methodologies we have developed, amended, adopted and the projects we have successfully undertaken. 2006-2018 Genos Consulting Inc.
Site du Genoscope
Comment soumettre un projet. Plateforme de criblage enzymatique. Fête de la Science. Pour les enseignants and les étudiants. Soumission de projet de séquençage. A propos du Genoscope. Soumission de projet de séquençage. Diversité microbienne des eaux usées. Génomique métabolique. Atelier de génomique comparative. Réseaux métaboliques. Dernières actualités. Communiqué de presse Tara. Soumissions projets de séquençage. APPEL A PROPOSITIONS 2015 « Grands Projets de Séquençage. Fax: ( 33) 0 1 60 87 25 14.
Error
Regres oznak starzenia się skóry. Zdrowie skóry, włosów i paznokci. Zdrowa i piekna cera. Trudno gojące się rany. Kości, stawy i ścięgna. Kontakt: ul. Ostrobramska 101, 04-041 Warszawa, tel. (22) 213 07 29, fax (22) 465 65 36, biuro@genoscope.pl.
